CORRECTION article
Front. Endocrinol.
Sec. Clinical Diabetes
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1683829
Correction: Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis
Provisionally accepted
- 1Hainan Vocational University of Science and Technology, Haikou, China
- 2The Chinese University of Hong Kong, Shatin, China
- 3Youjiang Medical University for Nationalities, Baise, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Keywords: tirzepatide, Weight Loss, Meta-analysis, Obesity, type 2 diabetes, adverse events
Received: 11 Aug 2025; Accepted: 15 Aug 2025.
Copyright: © 2025 Tian, Song, Deng and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yan Deng, The Chinese University of Hong Kong, Shatin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.